These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6742424)

  • 1. Stability of perfluorocarbon blood substitutes determined by sedimentation field-flow fractionation.
    Yang FS; Caldwell KD; Giddings JC; Astle L
    Anal Biochem; 1984 May; 138(2):488-94. PubMed ID: 6742424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid-gas partition coefficients of halothane and isoflurane in perfluorodecalin, fluosol-DA, and blood/fluosol-DA mixtures.
    Tremper KK; Zaccari J; Cullen BF; Hufstedler SM
    Anesth Analg; 1984 Jul; 63(7):690-2. PubMed ID: 6731898
    [No Abstract]   [Full Text] [Related]  

  • 3. Red blood cell substitutes and artificial blood.
    Bowman RJ
    Hum Pathol; 1983 Mar; 14(3):218-20. PubMed ID: 6832769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the perfluorocarbon Fluosol-DA in coronary angioplasty.
    Kerins DM
    Am J Med Sci; 1994 Mar; 307(3):218-21. PubMed ID: 8160713
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of a perfluorocarbon emulsion, Fluosol-DA, on rat lymphoid tissue and immunological competence.
    Bollands AD; Lowe KC
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1986; 85(2):309-12. PubMed ID: 2879690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and clinical application of perfluorochemical artificial blood.
    Ohyanagi H; Saitoh Y
    Int J Artif Organs; 1986 Sep; 9(5):363-8. PubMed ID: 3781670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particle size distribution of concentrated perfluorocarbon emulsions by sedimentation field flow fractionation.
    Klein DH; Burtner DB; Trevino LA; Arlauskas RA
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):859-64. PubMed ID: 1391524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of fluorocarbon emulsions in cancer radiotherapy.
    Guichard M
    Radiother Oncol; 1991; 20 Suppl 1():59-64. PubMed ID: 2020771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Fluosol-DA on radioimmunoassay results.
    Hammarstrom M; Mullins R; Sgoutas D
    Clin Chem; 1983 Jul; 29(7):1418-21. PubMed ID: 6861348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma-mediated alterations of erythrocyte deformability by perfluorochemical blood substitutes.
    Holloway GM; O'Rear EA; Fung BM
    Blood; 1986 Jan; 67(1):173-6. PubMed ID: 3940545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorocarbon emulsions: methodology to assess efficacy.
    Rosen AL; Sehgal LR; Gould SA; Sehgal H; Dalton L; Rice CL; Moss GS
    Crit Care Med; 1982 Mar; 10(3):149-54. PubMed ID: 7060386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole body oxygenation using intraperitoneal perfusion of fluorocarbons.
    Faithfull NS; Klein J; van der Zee HT; Salt PJ
    Br J Anaesth; 1984 Aug; 56(8):867-72. PubMed ID: 6430312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipyrine kinetics following partial blood exchange with Fluosol-DA in the rat.
    Shrewsbury RP; White SG; Pollack GM; Wargin WA
    J Pharm Pharmacol; 1986 Dec; 38(12):883-7. PubMed ID: 2880960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive transfusion of perfluorocarbon emulsion (Fluosol-DA) in newborn piglets.
    Hall JE; Karlson KH; DuRant RH
    Dev Pharmacol Ther; 1987; 10(3):163-73. PubMed ID: 3608746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An experimental study on fluorocarbons as blood substitutes.
    Motta G; Ratto GB; De Barbieri A; Tomellini M; Rovatti M; Sacco A; Castagnola M
    Ital J Surg Sci; 1983; 13(2):89-93. PubMed ID: 6629736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attempts to increase intratumoral blood flow in the rat solid Walker 256 tumor by the use of the perfluorocarbon emulsion fluosol-DA.
    Klubes P; Hiraga S; Cysyk RL; Owens ES; Blasberg RG
    Eur J Cancer Clin Oncol; 1987 Dec; 23(12):1859-67. PubMed ID: 3436350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatibility studies with a novel perfluorochemical emulsion.
    Bollands AD; Lowe KC; Sharma SK; Davis SS
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):451-3. PubMed ID: 3179482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in human cultured cells exposed to a perfluorocarbon emulsion.
    Wake EJ; Studzinski GP; Bhandal A
    Transfusion; 1985; 25(1):73-7. PubMed ID: 2982223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluosol DA-20% in treatment of severe anemia: ongoing studies in 52 patients.
    Spence RK; McCoy S; Costabile J; Norcross ED; Pello M; Alexander J; Atabek U; Wisdom C; Camishion R
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1069. PubMed ID: 1391428
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in plasma enzyme concentrations in response to blood substitution with perfluorocarbon emulsion in the conscious rat.
    Lowe KC; McNaughton DC
    Experientia; 1986 Dec; 42(11-12):1228-31. PubMed ID: 3780945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.